DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 5, 2005--Elan Corporation, plc announces that it will present at the JP Morgan 23rd Annual Healthcare Conference in San Francisco on Tuesday, January 11, 2005 at 1.30 p.m. Pacific Standard Time, 4.30 p.m. Eastern Standard Time and 9.30 p.m. Greenwich Mean Time. Interested parties may access a live audio webcast of the presentation by visiting Elan's website at www.elan.com and clicking on the Investor Relations section, then on the event icon.
About Elan
Elan is a neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing, selling and marketing advanced therapies in neurodegenerative diseases, autoimmune diseases and severe pain. Elan's (NYSE: ELN) shares trade on the New York, London and Dublin Stock Exchanges.
CONTACT: Elan Corporation, plcCopyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use